Medicure Inc

NGQ1

Company Profile

  • Business description

    Medicure Inc is focused on the development and commercialization of pharmaceuticals and healthcare products for patients and prescribers in the United States market and sales to the Retail Public of pharmaceutical products. The Company's present focus is the sale and marketing of its cardiovascular products, AGGRASTAT, ZYPITAMAG, and increasing its e-commerce and mail order pharmaceutical business. The Company operates under two segments: the marketing and distribution of commercial products and the operation of a retail and mail order pharmacy. It generates the majority of its revenue from the Retail and Mail Order Pharmacy segment.

  • Contact

    1250 Waverley Street
    No. 2
    WinnipegMBR3T 6C6
    CAN

    T: +1 204 487-7412

    E: [email protected]

    https://www.medicure.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 December 2026

    Employees

    22

Stocks News & Analysis

stocks

This ASX share just lost its moat

We revisit our long-term earnings assumptions and thesis.
stocks

ASX gold miner overvalued despite stronger gold prices

Higher gold prices boosted profit yet shares remain materially overvalued.
stocks

ASX energy giant undervalued despite commissioning challenges

Near-term hurdles, long-term upside.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,199.7030.700.33%
CAC 408,408.2750.51-0.60%
DAX 4025,460.483.53-0.01%
Dow JONES (US)52,118.37628.95-1.19%
FTSE 10010,908.4137.390.34%
HKSE25,807.92497.071.96%
NASDAQ24,822.6354.28-0.22%
Nikkei 22561,434.19930.73-1.49%
NZX 50 Index13,976.67114.740.83%
S&P 5007,406.3422.44-0.30%
S&P/ASX 2009,038.6035.100.39%
SSE Composite Index3,828.4715.150.40%

Market Movers